Patients
| Country | Value | Year |
|---|---|---|
| France | 22.5 | 2025 |
| Germany | 23.7 | 2025 |
| Italy | 25.1 | 2025 |
| Russia | 17.8 | 2025 |
| Spain | 21.6 | 2025 |
| UK | 19.7 | 2025 |
Updated
Reviewed by Vidhi Upadhyay
Europe Hearing Aids (OTC) Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$408.3 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $250.1 Mn | — | — |
| 2025 (base) | $276.6 Mn | +$26.5 Mn | — |
| 2026 (forecast) | $305.9 Mn | +$29.3 Mn | +10.6% |
| 2027 (forecast) | $338.3 Mn | +$32.4 Mn | +22.3% |
| 2028 (forecast) | $374.2 Mn | +$35.9 Mn | +35.3% |
| 2029 (forecast) | $413.8 Mn | +$39.7 Mn | +49.6% |
| 2030 (forecast) | $457.7 Mn | +$43.9 Mn | +65.5% |
| 2031 (forecast) | $506.2 Mn | +$48.5 Mn | +83% |
| 2032 (forecast) | $559.9 Mn | +$53.7 Mn | +102.4% |
| 2033 (forecast) | $619.2 Mn | +$59.3 Mn | +123.9% |
| 2034 (forecast) | $684.9 Mn | +$65.6 Mn | +147.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $276.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $684.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and channel (see all) |
| Key players | Sonova Holding AG, WS Audiology, GN Store Nord, Eargo, Apple Inc. and 1 more (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Over-the-counter hearing aids are sold directly to adults with mild to moderate hearing loss, without a prescription or fitting by a specialist.
Key segments of the hearing Aids (OTC) market include product (Behind-the-Ear, In-the-Ear and Earbud-Style) and channel (Retail Pharmacies, Online and Electronics Stores).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the hearing Aids (OTC) market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the hearing Aids (OTC) market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the hearing Aids (OTC) market.
The hearing Aids (OTC) market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Ministry of Health. Checked 14 Nov 2026.
[5] Roszdravnadzor. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Commission, health technology assessment. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hearing Aids (OTC) products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
What doctors and scientists are doing in Hearing Aids (OTC) right now, from free public sources.
| Country | Value | Year |
|---|---|---|
| France | 22.5 | 2025 |
| Germany | 23.7 | 2025 |
| Italy | 25.1 | 2025 |
| Russia | 17.8 | 2025 |
| Spain | 21.6 | 2025 |
| UK | 19.7 | 2025 |
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Europe · 1 shared keyword
Healthcare Services · Europe
Digital Health · Europe
Pharmaceuticals · Europe
Digital Health · Europe
Healthcare Services · Europe
OTC & Nutraceuticals · Europe